13F HOLDINGS REPORT
TANG CAPITAL MANAGEMENT LLC
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001214659-23-007174
Total Value
$671.1M
Positions
103
Other Managers
1
Confidential Omitted
No
Holdings (103)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ANAPTYSBIO INC | ANABV | 2,032,561 | $44.2M | 6.59% |
| 2 | BLUEBIRD BIO INC | 09609G100 | 9,882,827 | $31.4M | 4.68% |
| 3 | MIRUM PHARMACEUTICALS INC | MIRM | 1,170,000 | $28.1M | 4.19% |
| 4 | EVOLUS INC | EOLS | 3,197,399 | $27.0M | 4.03% |
| 5 | TARSUS PHARMACEUTICALS INC | TARS | 2,034,158 | $25.6M | 3.81% |
| 6 | NOVO-NORDISK A S | NONOF | 135,000 | $21.5M | 3.20% |
| 7 | MODERNA INC | MRNA | 136,700 | $21.0M | 3.13% |
| 8 | KALVISTA PHARMACEUTICALS INC | KALV | 2,651,393 | $20.8M | 3.11% |
| 9 | IMMUNOCORE HLDGS PLC | IMCR | 405,600 | $20.1M | 2.99% |
| 10 | AXSOME THERAPEUTICS INC | AXSM | 320,000 | $19.7M | 2.94% |
| 11 | BEIGENE LTD | BEIGF | 85,000 | $18.3M | 2.73% |
| 12 | VIRIDIAN THERAPEUTICS INC | VRDN | 692,925 | $17.6M | 2.63% |
| 13 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 300,000 | $16.2M | 2.42% |
| 14 | NEW YORK CMNTY BANCORP INC | 649445103 | 1,606,600 | $14.5M | 2.16% |
| 15 | ADICET BIO INC | ACET | 2,520,000 | $14.5M | 2.16% |
| 16 | BIOCRYST PHARMACEUTICALS INC | BCRX | 1,600,000 | $13.3M | 1.99% |
| 17 | ASTRAZENECA PLC | AZN | 170,000 | $11.8M | 1.76% |
| 18 | ALTIMMUNE INC | ALT | 2,750,000 | $11.6M | 1.73% |
| 19 | VAXCYTE INC | PCVX | 300,000 | $11.2M | 1.68% |
| 20 | HARMONY BIOSCIENCES HLDGS IN | HRMY | 321,200 | $10.5M | 1.56% |
| 21 | LILLY ELI & CO | LLY | 30,000 | $10.3M | 1.54% |
| 22 | PYXIS ONCOLOGY INC | PYXS | 2,481,662 | $10.0M | 1.48% |
| 23 | ZYMEWORKS DEL INC | ZYME | 1,100,000 | $9.9M | 1.48% |
| 24 | JOUNCE THERAPEUTICS INC | 481116101 | 5,300,087 | $9.8M | 1.46% |
| 25 | BIOATLA INC | BCAB | 3,624,076 | $9.7M | 1.45% |
| 26 | CAPITAL ONE FINL CORP | 14040H105 | 100,000 | $9.6M | 1.43% |
| 27 | CYTOMX THERAPEUTICS INC | CTMX | 6,093,032 | $9.2M | 1.37% |
| 28 | ALNYLAM PHARMACEUTICALS INC | ALNY | 45,000 | $9.0M | 1.34% |
| 29 | AMARIN CORP PLC | AMRN | 5,400,000 | $8.1M | 1.21% |
| 30 | BIO RAD LABS INC | 090572207 | 16,000 | $7.7M | 1.14% |
| 31 | THIRD HARMONIC BIO INC | 88427A107 | 1,800,000 | $7.4M | 1.11% |
| 32 | IONIS PHARMACEUTICALS INC | IONS | 200,000 | $7.1M | 1.07% |
| 33 | BELLEROPHON THERAPEUTICS INC | 078771300 | 893,974 | $7.1M | 1.05% |
| 34 | KINIKSA PHARMACEUTICALS LTD | KNSA | 600,000 | $6.5M | 0.96% |
| 35 | NKARTA INC | NKTX | 1,785,829 | $6.3M | 0.94% |
| 36 | COMERICA INC | 200340107 | 133,525 | $5.8M | 0.86% |
| 37 | QUINCE THERAPEUTICS INC | QNCX | 3,620,000 | $5.6M | 0.84% |
| 38 | ENZO BIOCHEM INC | 294100102 | 2,300,000 | $5.6M | 0.83% |
| 39 | CULLINAN ONCOLOGY INC | CGEM | 500,000 | $5.1M | 0.76% |
| 40 | TCR2 THERAPEUTICS INC | 87808K106 | 3,399,745 | $5.1M | 0.76% |
| 41 | GENFIT S A | 372279109 | 1,212,515 | $5.0M | 0.74% |
| 42 | GRAPHITE BIO INC | 38870X104 | 2,028,466 | $5.0M | 0.74% |
| 43 | IMMUNOGEN INC | 45253H101 | 1,274,853 | $4.9M | 0.73% |
| 44 | MAGENTA THERAPEUTICS INC | 55910K108 | 6,050,000 | $4.8M | 0.72% |
| 45 | CITIGROUP INC | C-PR | 100,000 | $4.7M | 0.70% |
| 46 | FATE THERAPEUTICS INC | FATE | 700,000 | $4.0M | 0.59% |
| 47 | FIRST REP BK SAN FRANCISCO C | 33616C100 | 278,759 | $3.9M | 0.58% |
| 48 | ENANTA PHARMACEUTICALS INC | ENTA | 90,000 | $3.6M | 0.54% |
| 49 | GALAPAGOS NV | GLPGF | 89,650 | $3.5M | 0.52% |
| 50 | ATEA PHARMACEUTICALS INC | AVIR | 1,002,582 | $3.4M | 0.50% |
| 51 | ASLAN PHARMACEUTICALS LTD | 04522R200 | 1,165,301 | $3.4M | 0.50% |
| 52 | CVB FINL CORP | 126600105 | 200,000 | $3.3M | 0.50% |
| 53 | ALIGOS THERAPEUTICS INC | ALGS | 3,424,800 | $3.0M | 0.45% |
| 54 | ITEOS THERAPEUTICS INC | 46565G104 | 216,700 | $2.9M | 0.44% |
| 55 | DYNAVAX TECHNOLOGIES CORP | 268158201 | 300,000 | $2.9M | 0.44% |
| 56 | ESPERION THERAPEUTICS INC NE | ESPR | 1,850,000 | $2.9M | 0.44% |
| 57 | AMYLYX PHARMACEUTICALS INC | AMLX | 100,000 | $2.9M | 0.44% |
| 58 | INSMED INC | INSM | 166,203 | $2.8M | 0.42% |
| 59 | ARCUS BIOSCIENCES INC | RCUS | 147,920 | $2.7M | 0.40% |
| 60 | ARS PHARMACEUTICALS INC | SPRY | 409,463 | $2.7M | 0.40% |
| 61 | ELEVATION ONCOLOGY INC | 28623U101 | 1,400,000 | $2.7M | 0.40% |
| 62 | 2SEVENTY BIO INC | 901384107 | 250,000 | $2.5M | 0.38% |
| 63 | EAGLE PHARMACEUTICALS INC | 269796108 | 80,000 | $2.3M | 0.34% |
| 64 | BOLT BIOTHERAPEUTICS INC | BOLT | 1,627,553 | $2.3M | 0.34% |
| 65 | BANKUNITED INC | BKU | 100,000 | $2.3M | 0.34% |
| 66 | PROMETHEUS BIOSCIENCES INC | 74349U108 | 21,000 | $2.3M | 0.34% |
| 67 | ARVINAS INC | ARVN | 80,000 | $2.2M | 0.33% |
| 68 | BELLUS HEALTH INC NEW | 07987C204 | 300,000 | $2.2M | 0.32% |
| 69 | EQUITY COMWLTH | 294628102 | 100,000 | $2.1M | 0.31% |
| 70 | VERITEX HLDGS INC | 923451108 | 110,000 | $2.0M | 0.30% |
| 71 | IMMUNITYBIO INC | IBRX | 1,095,795 | $2.0M | 0.30% |
| 72 | ALLAKOS INC | 01671P100 | 447,967 | $2.0M | 0.30% |
| 73 | BIOHAVEN LTD | BHVN | 140,000 | $1.9M | 0.28% |
| 74 | SERVISFIRST BANCSHARES INC | SFBS | 30,000 | $1.6M | 0.24% |
| 75 | COHERUS BIOSCIENCES INC | CHRS | 200,000 | $1.4M | 0.20% |
| 76 | MEI PHARMA INC | 55279B202 | 5,163,456 | $1.2M | 0.18% |
| 77 | UMB FINL CORP | 902788108 | 20,000 | $1.2M | 0.17% |
| 78 | SCYNEXIS INC | SCYX | 383,179 | $1.1M | 0.17% |
| 79 | SURFACE ONCOLOGY INC | 86877M209 | 1,300,000 | $908,440 | 0.14% |
| 80 | ATHIRA PHARMA INC | 04746L104 | 352,715 | $881,788 | 0.13% |
| 81 | HERON THERAPEUTICS INC | HRTX | 550,000 | $830,500 | 0.12% |
| 82 | TANGO THERAPEUTICS INC | TNGX | 200,000 | $790,000 | 0.12% |
| 83 | VANDA PHARMACEUTICALS INC | VNDA | 100,000 | $679,000 | 0.10% |
| 84 | TONIX PHARMACEUTICALS HLDG C | TNXP | 1,100,419 | $650,458 | 0.10% |
| 85 | NEXTCURE INC | NXTC | 400,000 | $592,000 | 0.09% |
| 86 | INVIVYD INC | IVVD | 400,000 | $480,000 | 0.07% |
| 87 | LIANBIO | LIANY | 209,600 | $410,816 | 0.06% |
| 88 | PARDES BIOSCIENCES INC | 69945Q105 | 300,000 | $396,000 | 0.06% |
| 89 | INSPIRATO INCORPORATED | 45791E107 | 380,000 | $364,382 | 0.05% |
| 90 | KRONOS BIO INC | 50107A104 | 200,000 | $292,000 | 0.04% |
| 91 | PASSAGE BIO INC | PASG | 300,000 | $287,310 | 0.04% |
| 92 | ORCHARD THERAPEUTICS PLC | 68570P200 | 50,000 | $268,500 | 0.04% |
| 93 | ATYR PHARMA INC | ATYR | 123,430 | $259,203 | 0.04% |
| 94 | STELLAR BANCORP INC | STEL | 10,000 | $246,100 | 0.04% |
| 95 | MOLECULAR PARTNERS AG | MOLN | 38,253 | $230,968 | 0.03% |
| 96 | REVIVA PHARMACEUTCLS HLDGS I | 76152G100 | 53,200 | $222,908 | 0.03% |
| 97 | CYTEIR THERAPEUTICS INC | 23284P103 | 100,000 | $182,000 | 0.03% |
| 98 | INSTIL BIO INC | TIL | 200,000 | $132,160 | 0.02% |
| 99 | ACELRX PHARMACEUTICALS INC | TLPH | 195,000 | $128,310 | 0.02% |
| 100 | VINCERX PHARMA INC | VNCE | 101,762 | $105,832 | 0.02% |
| 101 | NEKTAR THERAPEUTICS | NKTR | 139,600 | $98,125 | 0.01% |
| 102 | EQUILLIUM INC | EQ | 88,568 | $64,655 | 0.01% |
| 103 | AVROBIO INC | 05455M100 | 37,613 | $37,613 | 0.01% |